Mediators involved in the cancer anorexia-cachexia syndrome: Past, present, and future

Nutrition

Volumn 21, Issue 9, 2005, Pages 977-985

  Argilés, Josep M ^a   Busquets, Sílvia ^a   García Martínez, Cèlia ^a   López Soriano, Francisco J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cytokines; Therapeutical strategies; Transcriptional factors

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ANEMIA INDUCING SUBSTANCE; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; GHRELIN; HYPOPHYSIS HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR; LIPID MOBILIZER HORMONE; MYOD PROTEIN; PENTOXIFYLLINE; POLYPEPTIDE; PROTEOLYSIS INDUCING FACTOR; PROTEOLYSIS INDUCING FACTOR RECEPTOR; ROLIPRAM; TOXOHORMONE L; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3; UNINDEXED DRUG;

ANOREXIA; ASCITES HEPATOMA; CACHEXIA; CANCER; CARCINOMA CELL; CATABOLISM; DISEASE ASSOCIATION; HUMAN; MEDIATOR RELEASE; MOLECULAR DYNAMICS; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; REVIEW;

CACHEXIA; CYTOKINES; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 23944497580     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2005.02.003     Document Type: Review

References (87)

1. J. López-Soriano, N. Carbó, L. Tessitore, F.J. López-Soriano, J.M. Argilés Leptin and tumour growth in the rat Int J Cancer 81 1999 726 729
2. T. Sato, M.M. Meguid, G. Miyata, C. Chen, K. Hatakeyama Does leptin really influence cancer anorexia? Nutrition 18 2002 82 83
3. A. Kowalczuk, A. Wiecek, E. Franek, F. Kokot Plasma concentration of leptin, neuropeptide Y and tumour necrosis factor alpha in patients with cancers, before and after radio- and chemotherapy Pol Arch Med Wewn 106 2001 657 668
4. L. Tessitore, B. Vizio, O. Jenkins, I. De Stefano, C. Ritossa, J.M. Argilés Leptin expression in colorectal and breast cancer patients Int J Mol Med 5 2000 421 426
5. D.R. Brown, D.E. Berkowitz, M.J. Breslow Weight loss is not associated with hyperleptinemia in humans with pancreatic cancer J Clin Endocrinol Metab 86 2001 162 166
6. M.R. Aleman, F. Santolaria, N. Batista, M. de La Vega, E. Gonzalez-Reimers, A. Milena Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? Cytokine 19 2002 21 26
7. G. Mantovani, A. Maccio, L. Mura, E. Massa, M.C. Mudu, C. Mulas Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites J Mol Med 78 2000 554 561
8. G. Mantovani, A. Maccio, C. Madeddu, L. Mura, E. Massa, M.C. Mudu Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites J Mol Med 179 2000 406 414
9. M. Korbonits, A.B. Grossman Ghrelin update on a novel hormonal system Eur J Endocrinol 151 2004 S67 S70
10. T. Hanada, K. Toshinai, Y. Date, N. Kajimura, T. Tsukada, Y. Hayashi Upregulation of ghrelin expression in cachectic nude mice bearing human melanoma cells Metabolism 53 2004 84 88
11. B.E. Wisse, M.W. Schwartz, D.E. Cummings Melanocortin signaling and anorexia in chronic disease states Ann NY Acad Sci 994 2003 275 281
12. D.L. Marks, R.D. Cone The role of the melanocortin-3 receptor in cachexia Ann NY Acad Sci 994 2003 258 266
13. C.R. Plata-Salaman Central nervous system mechanisms contributing to the cachexia-anorexia syndrome Nutrition 16 2000 1009 1012
14. W.T. Chance, A. Balasubramaniam, R. Dayal, J. Brown, J.E. Fischer Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumour-bearing rats Life Sci 54 1994 1869 1874
15. P.J. King, P.S. Widdowson, H. Doods, G. Williams Effect of cytokines on hypothalamic neuropeptide Y release in vitro Peptides 21 2000 143 146
16. A. Laviano, M. Russo, F. Freda, F. Rossi-Fanelli Neurochemical mechanisms for cancer anorexia Nutrition 18 2002 100 105
17. C. Bing, S. Taylor, M.J. Tisdale, G. Williams Cachexia in MAC16 adenocarcinoma suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y J Neurochem 79 2001 1004 1012
18. G. Strassmann, M. Fong, C.E. Freter, S. Windsor, F. D'Alessandro, R.P. Nordan Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo J Clin Invest 92 1993 2152 2159
19. A. Enomoto, M.C. Rho, A. Fukami, O. Hiraku, K. Komiyama, M. Hayashi Suppression of cancer cachexia by 20S,21-epoxy-resibufogenin-3-acetate - a novel nonpeptide IL-6 receptor antagonist Biochem Biophys Res Commun 323 2004 1096 1102
20. B.E. Barton, J. Cullison, J. Jackson, T. Murphy A model that reproduces syndromes associated with human multiple myeloma in nonirradiated SCID mice Proc Soc Exp Biol Med 223 2000 190 197
21. B.E. Barton, T.F. Murphy Cancer cachexia is mediated in part by the induction of IL-6-like cytokines from the spleen Cytokine 16 2001 251 257
22. D.R. Negri, D. Mezzanzanica, S. Sacco, M. Gadina, F. Benigni, L. Cajola Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours Cytokine 15 2001 27 38
23. M.H. Zaki, J.A. Nemeth, M. Trikha CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice Int J Cancer 111 2004 592 595
24. P. Matthys, H. Heremans, G. Opdenakker, A. Billiau Anti-interferon- γ antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia Eur J Cancer 27 1991 182 187
25. J.T. Henderson, B.J. Mullen, J.C. Roder Physiological effects of CNTF-induced wasting Cytokine 8 1996 784 793
26. M.C. Wang, N.E. Forsberg Effects of ciliary neurotrophic factor (CNTF) on protein turnover in cultured muscle cells Cytokine 12 2000 41 48
27. S.H. Adams Uncoupling protein homologs emerging views of physiological function J Nutr 130 2000 711 714
28. S. Busquets, D. Sanchis, B. Alvarez, D. Ricquier, F.J. López-Soriano, J.M. Argilés In the rat, TNF-α administration results in an increase in both UCP2 and UCP3 mRNAs in skeletal muscle a possible mechanism for cytokine-induced thermogenesis? FEBS Lett 440 1998 348 350
29. S. Busquets, X. Aranda, M. Ribas-Carbó, J. Azcon-Bieto, F.J. López-Soriano, J.M. Argilés Tumour necrosis factor-alpha uncouples respiration in isolated rat mitochondria Cytokine 22 2003 1 4
30. J.M. Argilés, F.J. López-Soriano Catabolic proinflammatory cytokines Curr Opin Clin Nutr Metab Care 1 1998 245 251
31. M. Bossola, M. Muscaritoli, P. Costelli, R. Bellantone, F. Pacelli, S. Busquets Increased muscle ubiquitin mRNA levels in gastric cancer patients Am J Physiol 280 2001 R1518 R1523
32. V.E. Baracos Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia Nutrition 16 2000 1015 1018
33. B. Alvarez, L.S. Quinn, S. Busquets, M.T. Quiles, F.J. López-Soriano, J.M. Argilés Tumour necrosis factor-alpha exerts interleukin-6-dependent and -independent effects on cultured skeletal muscle cells Biochim Biophys Acta 1542 2002 66 72
34. R. Sharma, S.D. Anker Cytokines, apoptosis and cachexia the potential for TNF-α antagonism Int J Cardiol 85 2002 161 171
35. M. van Royen, N. Carbó, S. Busquets, B. Alvarez, L.S. Quinn, F.J. López-Soriano, J.M. Argilés DNA fragmentation occurs in skeletal muscle during tumour growth a link with cancer cachexia? Biochem Biophys Res Commun 270 2000 533 537
36. J.E. Belizario, M.J. Lorite, M.J. Tisdale Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia Br J Cancer 84 2001 1135 1140
37. N. Carbó, S. Busquets, M. van Royen, B. Alvarez, F.J. López-Soriano, J.M. Argilés TNF-α is involved in activating DNA fragmentation in murine skeletal muscle Br J Cancer 86 2002 1012 1016
38. R.J. Dunlop, C.W. Campbell Cytokines and advanced cancer J Pain Symptom Manage 20 2000 214 232
39. C. Cahlin, A. Korner, H. Axelsson, W. Wang, K. Lundholm, E. Svanberg Experimental cancer cachexia the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia Cancer Res 60 2000 5488 5493
40. G. Costa, J.F. Holland Effects of Krebs-2 carcinoma on the lipid metabolism of male Swiss mice Cancer Res 22 1966 1081 1083
41. S. Kitada, E.F. Hays, J.F. Mead Characterization of a lipid mobilizing factor from tumors Prog Lipid Res 20 1981 823 826
42. H. Masuno, N. Yamasaki, H. Okuda Purification and characterization of a lipolytic factor (toxohormone L) from cell free fluid of ascites sarcoma 180 Cancer Res 41 1981 284 288
43. S. Khan, M.J. Tisdale Catabolism of adipose tissue by a tumour-produced lipid-mobilising factor Int J Cancer 80 1999 444 447
44. K. Hirai, H.J. Hussey, M.D. Barber, S.A. Price, M.J. Tisdale Biological evaluation of a lipid-mobilising factor isolated from the urine of cancer patients Cancer Res 58 1998 2359 2365
45. K. Hirai, O. Ishiko, M. Tisdale Mechanism of depletion of liver glycogen in cancer cachexia Biochim Biophys Res Commun 241 1997 49 52
46. O. Ishiko, T. Yasui, K. Hirai, K. Honda, T. Sumi, S. Nishimura, S. Ogita Lipolytic activity of anemia-inducing substance from tumor-bearing rabbits Nutr Cancer 33 1999 201 205
47. P. Todorov, P. Cariuk, T. McDevitt, B. Coles, K. Fearon, M. Tisdale Characterization of a cancer cachectic factor Nature 22 1996 739 742
48. M.J. Lorite, P. Cariuk, M.J. Tisdale Induction of muscle protein degradation by a tumour factor Br J Cancer 76 1997 1035 1040
49. S.J. Wigmore, P.T. Todorov, M.D. Barber, J.A. Ross, M.J. Tisdale, K.C. Fearon Characteristics of patients with pancreatic cancer expressing a novel cancer cachexia factor Br J Surg 87 2000 53 58
50. M.J. Lorite, M.G. Thompson, J.L. Drake, G. Carling, M.J. Tisdale Mechanism of muscle protein degradation induced by a cancer cachectic factor Br J Cancer 78 1998 850 856
51. H.J. Smith, M.J. Lorite, M.J. Tisdale Effects of a cancer cachectic factor on protein synthesis/degradation in murine C2C12 myoblasts modulation by eicosapentaenoic acid Cancer Res 59 1999 5507 5513
52. H.J. Smith, S.M. Wyke, M.J. Tisdale Role of protein kinase C and NF-kappaB in proteolysis-inducing factor-induced proteasome expression in C(2)C(12) myotubes Br J Cancer 90 2004 1850 1857
53. C.G. Penner, G. Gang, C. Wray, J.E. Fischer, P.O. Hasselgren The transcription factors NF-kappaB and AP-1 are differentially regulated in skeletal muscle during sepsis Biochem Biophys Res Commun 281 2001 1331 1336
54. P. Costelli, M. Muscaritoli, M. Bossola, R. Moore-Carrasco, S. Crepaldi, G. Grieco Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation Int J Oncol 26 2005 1663 1668
55. S. Busquets, N. Carbó, V. Almendro, M.T. Quiles, F.J. López-Soriano, J.M. Argilés Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model Cancer Lett 167 2001 33 38
56. R. Moore-Carrasco, S. Busquets, V. Almendro, M. Palanki, F.J. López-Soriano, J.M. Argilés The AP-1/nF-kB double inhibitor (SP100030) can revert muscle wasting during experimental cancer cachexia Int J Oncol 2005 in press.
57. L. Fernandez-Celemin, N. Pasko, V. Blomart, J.P. Thissen Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha Am J Physiol 283 2002 E1279 E1290
58. Y.P. Li, R.J. Schwartz, I.D. Waddell, B.R. Holloway, M.B. Reid Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha FASEB J 12 1998 871 880
59. Y.P. Li, M.B. Reid NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes Am J Physiol Regul Integr Comp Physiol 279 2000 R1165 R1170
60. D.A. Brenner, M. O'Hara, P. Angel, M. Chojkier, M. Karin Prolonged activation of jun and collagenase genes by tumor necrosis factor-alpha Nature 337 1989 661 663
61. G. Thinakaran, J. Ojala, J. Bag Expression of c-jun/AP-1 during myogenic differentiation in mouse C2C12 myoblasts FEBS Lett 319 1993 271 276
62. D. Cai, J.D. Frantz, N.E. Tawa Jr, P.A. Melendez, B.C. Oh, H.G. Lidov IKKbeta/NF-kappaB activation causes severe muscle wasting in mice Cell 119 2004 285 298
63. S. Acharyya, K.J. Ladner, L.L. Nelsen, J. Damrauer, P.J. Reiser, S. Swoap, D.C. Guttridge Cancer cachexia is regulated by selective targeting of skeletal muscle gene products J Clin Invest 114 2004 370 378
64. G.M. Diffee, K. Kalfas, S. Al-Majid, D.O. McCarthy Altered expression of skeletal muscle myosin isoforms in cancer cachexia Am J Physiol Cell Physiol 283 2002 C1376 C1382
65. G. Penner, G. Gang, X. Sun, C. Wray, P.O. Hasselgren C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle Am J Physiol 282 2002 R439 R444
66. D.C. Guttridge, M.W. Mayo, L.V. Madrid, C.Y. Wang, A.S. Baldwin Jr NF-kappaB-induced loss of MyoD messenger RNA possible role in muscle decay and cachexia Science 289 2000 2363 2366
67. D. Coletti, E. Yang, G. Marazzi, D. Sassoon TNF-α inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways EMBO J 21 2002 631 642
68. P. Puigserver, J. Rhee, J. Lin, Z. Wu, J.C. Yoon, C.Y. Zhang Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1 Mol Cell 8 2001 971 982
69. C. Balazs, E. Kiss Immunological aspects of the effect of pentoxifylline Acta Microbiol Immunol Hung 41 1994 121 126
70. R.M. Goldberg, C.L. Loprinzi, J.A. Mailliard, J.R. O'Fallon, J.E. Krook, C. Ghosh Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial J Clin Oncol 13 1995 2856 2859
71. V. Peuckmann, M. Fisch, E. Bruera Potential novel uses of thalidomide focus on palliative care Drugs 60 2000 273 292
72. Z.H. Khan, E.J. Simpson, A.T. Cole, M. Holt, I. MacDonald, D. Pye Oesophageal cancer and cachexia the effect of short-term treatment with thalidomide on weight loss and lean body mass Aliment Pharmacol Ther 17 2003 677 682
73. T.A. Babcock, W.S. Helton, D. Hong, N.J. Espat Omega-3 fatty acid lipid emulsion reduces LPS-stimulated macrophage TNF-alpha production Surg Infect 3 2002 145 149 (Larchmt)
74. Y. Liu, L. Gong, D. Li, Z. Feng, L. Zhao, T. Dong Effects of fish oil on lymphocyte proliferation, cytokine production and intracellular signalling in weanling pigs Arch Tierernahr 57 2003 151 165
75. T. Trebble, N.K. Arden, M.A. Stroud, S.A. Wootton, G.C. Burdge, E.A. Miles Inhibition of tumour necrosis factor-alpha and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation Br J Nutr 90 2003 405 412
76. P. Costelli, N. Carbó, L. Tessitore, G.J. Bagby, F.J. López-Soriano, J.M. Argilés, F.M. Baccino Tumor necrosis factor-α mediates changes in tissue protein turnover in a rat cancer cachexia model J Clin Invest 92 1993 2783 2789
77. K. Reinhart, C. Wiegand-Lohnert, F. Grimminger, M. Kaul, S. Withington, D. Treacher Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody fragment, MAK 195F, in patients with sepsis and septic shock a multicenter, randomized, placebo-controlled, dose-ranging study Crit Care Med 24 1996 733 742
78. J. Kurtovic, I. Segal Recent advances in biological therapy for inflammatory bowel disease Trop Gastroenterol 25 2004 9 14
79. P. Rutgeerts, G. Van Assche, S. Vermeire Optimizing anti-TNF treatment in inflammatory bowel disease Gastroenterology 126 2004 1593 1610
80. K. Mori, K. Fujimoto-Ouchi, T. Ishikawa, F. Sekiguchi, H. Ishitsuka, Y. Tanaka Murine interleukin-12 prevents the development of cancer cachexia in a murine model Int J Cancer 67 1996 849 855
81. L.S. Quinn, K.L. Haugk, K.H. Grabstein Interleukin-15 a novel anabolic cytokine for skeletal muscle Endocrinology 136 1995 3669 3672
82. N. Carbó, J. López-Soriano, P. Costelli, S. Busquets, B. Alvarez, F.M. Baccino Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats Br J Cancer 83 2000 526 531
83. T. Okamoto NSAID zaltoprofen improves the decrease in body weight in rodent sickness behavior models proposed new applications of NSAID Int J Mol Med 9 2002 369 372
84. Q. Niu, T. Li, A. Liu Cytokines in experimental cancer cachexia Zhonghua Zhong Liu Za Zhi 23 2001 382 384
85. K. Lundholm, P. Daneryd, I. Bosaeus, U. Korner, E. Lindholm Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease effects on survival, metabolism, and function Cancer 100 2004 1967 1977
86. I. Kawamura, R. Morishita, N. Tomita, E. Lacey, M. Aketa, S. Tsujimoto Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model Gene Ther 6 1999 91 97
87. I. Kawamura, R. Morishita, S. Tsujimoto, T. Manda, M. Tomoi, N. Tomita Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice Gene Ther 8 2001 905 912